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Several different agents including free radicals, oxidizing 
compounds and proteases are believed to play a role in the 
onset of arthritis. The evidence and underlying chemistry 
presently available for each destructive agent are presented. 
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I n t roduct ion  
Arthritis is the general term for a family of diseases charac- 
terized by joint inflammation, pain and swelling that lead to 
permanent joint damage and a loss of flexibility and mobil- 
ity. More than 40 million people suffer from some form of 
arthritis, making it not only a leading cause of disability in 
the United States, but also a heavy, burden on healthcare 
resources, especially geriatric medicine [1-4]. Of the many 
conditions characterized as arthritic disorders (e.g., 
osteoarthritis, rheumatoid arthritis, lupus, gout, bursitis, 
rheumatic fever and Lyme arthritis), osteoarthritis and 
rheumatoid arthritis account for most diagnoses. The 
National Institutes of Health report arthritis as the second 
most common diagnosis, after chronic heart disease, leading 
to long-term Social Security disability payments in the 
USA. Although risk factors certainly increase with age, 
arthritis afflicts individuals of every age, race and gender. 
More than one half of the people suffering from arthritis are 
under 65 years of age, with greater prevalence seen among 
women than men [2-4]. The Centers for Disease Control 
report higher proportions of patients uffering activity limi- 
tations attributable to arthritis among African Americans, 
North American Indians and Native Alaskans than among 
Caucasians and Asians/Pacific Islanders [5]. 
Osteoarthritis (OA), the most common form of arthritis, 
involves the destabilization of the normal balance 
between the degradation and the synthesis of articular car- 
tilage and subchondral bone within a joint [6]. As articular 
cartilage degrades over time, its smooth surface roughens 
and bone-against-bone contact ensues, producing the 
inflammation response symptomatic of this 'wear and tear' 
disease. Although a variety of genetic, developmental, 
metabolic and traumatic factors may initiate the develop- 
ment of osteoarthritis [7], its symptoms (joint pain, stiff- 
ness and curtailed function) typically evolve slowly, and 
patients experience periods of relative calm alternating 
with episodes of inflammation and pain [8]. Because diag- 
nosis requires X-ray analysis of the affected joints follow- 
ing the onset of pain, joint damage generally occurs prior 
to clinical diagnosis. Roughly one third of all white North 
American and Northern European adults exhibit features 
of osteoarthritis in at least one joint [7]. 
Rheumatoid arthritis (RA), an autoimmune disease of 
unknown etiology characterized by chronic synovitis and 
cartilage destruction, affects 1% of the total population [9]. 
This crippling disease, associated with such conditions as 
scleroderma, lupus, polymyositis, Reiter's syndrome and 
juvenile rheumatoid arthritis, involves the release of diges- 
tive enzymes within the joint as a result of prolonged 
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(a) The left section of the figure shows 
macroscopic representation f cartilage within 
a joint. The inset shows components of 
cartilage. Cartilage consists of chondrocytes 
embedded in an extracellular matrix of 
aggrecan and collagen. The collagen network 
traps proteoglycan aggregates (aggrecan), 
forming large polyanions capable of water 
sequestration. The resulting gel-like properties 
of cartilage cushion and protect bones within 
a joint. (b) A schematic diagram of
proteoglycan aggreagate (the boxed area is 
enlarged to show detail). Core protein 
fragments bearing glycosaminoglycan chains 
arrange themselves laterally at regular 
intervals along the hyaluronan backbone via 
noncovalent interactions with link proteins. 
inflammation of the synovial membrane. These enzymes 
lead to the production of a series of antibodies responsible 
for the degradation of cartilage, ligaments, tendons and 
bone [8,10]. The presence of one such antibody in the 
bloodstream, termed rheumatoid factor, often precedes the 
onset of outward symptoms as a diagnosis of rheumatoid 
arthritis. Nearly a quarter of all RA patients never develop 
this factor, however, and this antibody may be present in 
individuals who do not have RA, complicating its diagnosis 
[10]. Because of its systemic nature, RA can affect a variety 
of organs, including the heart, blood vessels, lungs and 
eyes, and can cause overall muscle aching and stiffness, 
fatigue, anemia nd low-grade fever [8]. 
Despite the differences in diagnosis, etiology and outward 
symptoms, rheumatoid and osteoarthritis maintain one 
defining common characteristic: the degradation of articu- 
lar cartilage. Cartilage and synovial fluid, persisting at the 
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articular surfaces on the bones of all movable joints, serve 
to cushion and lubricate the joint, enhancing the support, 
protection and smooth mechanical operation of the bones 
involved. Cartilage is a connective tissue consisting of 
chondrocytes embedded in an elastic ground substance or 
matrix composed of collagen and a proteoglycan gel 
(Figure 1) [11]. The type II collagen found in cartilaginous 
tissues incorporates a triple helix of hydrophilic hains that 
binds matrix macromolecules critical to cartilage stability. 
Cartilage elasticity stems from the proteoglycan gel, com- 
prised mainly of aggrecan units assembled along a hyaluro- 
nan skeleton. Aggrecan, the major proteoglycan of 
cartilage, contains many carbohydrate chains (keratin- and 
chondroitin-6-sulfate specifically) attached to a protein 
core that fastens itself to the hyaluronan backbone via a 
small link protein (Figure 2). The collagen network traps 
the proteoglycan aggregates to form large polyanions 
capable of sequestering water in the matrix, thereby con- 
ferring the gel-like properties of aggrecan and the cushion- 
ing properties of cartilage [12]. Iqyaluronic acid (HA, also 
referred to as hyaluran), the principal component of syn- 
ovial fluid, also retains water, effecting gel formation and 
subsequent joint lubrication. 
In arthritic joints, the chemical components of cartilage 
and synovial fluid degrade, reducing their ability to retain 
water and limiting their protective properties. A detailed 
understanding of these processes i a necessary prerequi- 
site in the development of therapeutic and preventive 
methodologies to control disease progression. Research 
indicates that fragments of core protein, keratin sulfate, 
Figure 2 
chondroitin sulfate, collagen and hyaluronan exist in 
increased concentrations in arthritic cartilage, as do matrix 
metalloproteinases that serve to degrade cartilaginous pro- 
teins [13] (Figure 3). Examination of the components of 
arthritic cartilage from chemical, biochemical [14-16] and 
genetic [17-19] perspectives has suggested possible mech- 
anisms by which cartilage and synovial fluid degradation 
occur. Investigation of the potential factors involved in 
osteoarthritis mplicates the participation of free radicals, 
nitric oxide (NO), and matrix metalloproteinases, one or 
more of which may trigger the depolymerization of HA 
and the release of proteolytic enzymes responsible for the 
destruction of constitutive cartilaginous proteins [6]. This 
review focuses on the investigation of these factors as they 
relate to the depolymerization of HA and the potential 
mechanisms by which this degradation might occur at the 
molecular level. 
Effect of free radicals on HA structure 
Research implicates the degradation of HA as a major 
cause of arthritis [20-23]. Serving as the skeleton upon 
which the proteoglycan complex assembles, HA is a key 
structural component of articular cartilage, although it 
accounts for only 1% of its composition (Figure 4). In addi- 
tion, the link and core proteins utilized in the formation of 
proteoglycan gel require an HA decasaccharide in order for 
complexation of aggrecan to the HA backbone to occur 
[24,25]. As a result, the degradation of HA serves a dual 
role in the destruction and disintegration of cartilaginous 
tissues. Appropriately, a voluminous body of work focuses 
on the elucidation of HA degradation, the consensus being 
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The degradation of aggrecan. The 
depolymerization of HA results in collapse of 
the structural scaffold of the aggrecan 
complex, reducing its ability to retain water 
and diminishing its gel-like properties. 
that free radicals participate, although the means of partici- 
pation and the species involved remain in question. 
Species hypothesized to participate in the depolymeriza- 
tion of HA are reactive oxygen species (ROS; e.g., hydro- 
gen peroxide, hypochlorous acid, singlet oxygen, 
superoxide radical and hydroxyl radical) generated in the 
presence of Fe z+, xanthine and xanthine oxidase (HX/XO) 
and myeloperoxidase (Figure 5) [20]. Although these 
systems actively engage in carbohydrate degradation 
processes, the conditions required for the production of 
ROS in vivo remain elusive. 
Exposure of polycyclic aromatic hydrocarbons toUV light 
produces reversibly photooxidizable peroxide sp cies that 
liberate singlet oxygen, a ROS capable of HA degrada- 
tion. Lapcik and Schurz [26] utilized the singlet-oxygen 
Figure 4 
sensitizing system anthracene-l-sulfonic acid (A-SOsH) 
to investigate the degradation process provoked by UV 
radiation. They exposed aqueous solutions of HA to UV 
radiation both in the presence of and in the absence of 
sensitizer. Although those solutions containing sensitizer 
lost all elasticity, those without sensitizer showed remark- 
able decreases in viscosity as well, indicating the dramatic 
degradation of HA by UV radiation both with and without 
sensitizer. In fact, high-performance liquid chromatogra- 
phy (HPLC) analysis demonstrated degradation of HA 
after just 60 minutes of UV exposure. 
In an effort o identify the intermediate radicals involved in 
the UV depolymerization f HA, Lapcik et al. [27] used 
electron paramagnetic resonance (EPR) spin-trapping 
experiments ostudy the radicals generated by degradation. 
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Hyaluronic acid, showing the repeating 
glucuronic acid and N-acetyl glucosamine 
residues. 
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Although the authors identified four different radical 
species (three from sidechain groups, one from a ring 
carbon), they did not assign any of these species to the 
abstraction of a specific proton. Instead, they proposed that 
the carbon-centered ra icals form first, initiating HA degra- 
dation; they offer no proof in support of this hypothesis. 
Because the concomitant use of UV radiation and a sensi- 
tizer generates hydroxyl radicals in aqueous solution, it 
follows that this system provokes HA depolymerization. 
The work of Lapcik et al. [27] work, therefore, more appro- 
priately serves to demonstrate he role that radicals play in 
HA degradation and how EPR can be used to characterize 
radical products generated by depolymerization. 
Most HA depolymerization studies employ hydroxyl radi- 
cals as the reactive oxygen-containing species. Initial 
studies demonstrated a decrease in viscosity of HA solu- 
tions upon exposure to solutions containing iron (II) 
cations [28-30]. Iron (II) cations generate hydroxyl radicals 
via the Fenton, or Haber-Weiss, reaction first observed by 
Fenton in 1894 (Figure 6). The tiny amount of iron present 
in synovial fluid is sufficient o initiate Fenton chemistry, 
as the reaction requires only catalytic amounts of iron for 
hydroxyl radical production. In 1998, Miyazaki et al. [31] 
observed asignificant decrease in the viscosity of HA solu- 
tions stored in stainless-steel sample containers over 
several days. This observation led to the discovery that HA 
degradation can occur as a result of contact with metallic 
surfaces - -  trace amounts of iron can leach from the solid- 
state metal into solution. 
Historically, the oxidation of 80% of the ascorbic acid in 
the synovial fluid of patients with RA led researchers to 
believe that ascorbic acid might participate in HA depoly- 
merization [32]. Experiments have shown that HA 
degrades in the presence of ascorbic acid, and that it 
degrades at a faster ate in the presence of iron and ascorbic 
acid. In both cases, the addition of desferrioxamine, aniron 
chelator, completely inhibited HA degradation. This result 
indicated that ascorbic acid does not degrade HA; rather, 
the acid contains trace amounts of iron contaminants 
responsible for HA depolymerization [33-35]. Kvam et al. 
[36] proposed that the ascorbic acid reduces iron (III) to 
iron (II), increasing the rate of the Fenton reaction and 
thus the rate of HA degradation. Other metals shown to 
catalyze HA degradation i clude copper and manganese, 
present in the metalloproteins found in the extracellular 
matrix [37,38]. 
Hawkins and Davies [39] have employed electronic spin 
resonance (ESR) to extensively study hydroxyl radical 
attack on HA, as well as on related carbohydrate polymers 
and their constituents. Under Fenton conditions at pH 4, 
hydroxyl radical attack on glucuronic acid and N-acetyl 
glucosamine generated a variety of products. The authors 
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(a) Fenton reaction (net equation). (b  Sequential progression f the 
intermediate reactions involved in the Fenton reaction. Note the 
production of hydroxyl radical in the first step. 
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End groups isolated from HA depolymerization under Fenton 
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observed random proton abstraction for glucuronic acid 
and nearly random proton abstraction for N-acetyl glu- 
cosamine, with the exception of the N-acetyl methyl 
carbon and C(2), neither of which demonstrated radical 
formation. Any fluctuation in pH led to the disappearance 
of spectral features for glucuronic acid, indicating probable 
radical rearrangement, whereas for N-acetyl glucosamine, 
a decrease in pH led to the prolonged maintenance of its 
spectral features, demonstrating some increased stability. 
An equimolar mixture of glucuronic acid and N-acetyl glu- 
cosamine exhibited completely random attack with no 
preference shown for one sugar over the other; spin-trap- 
ping experiments on HA demonstrated the same pattern. 
These results suggest hat at least some initial radicals 
undergo base-catalyzed rearrangement reactions resulting 
in strand-cleavage and the formation of low-molecular- 
weight fragments of HA. 
Schiller etal. [40,41] employed nuclear magnetic resonance 
(NMR) spectroscopy to monitor the breakdown of mono- 
saccharides, HA and cartilage after subjection to irradiation 
or Fenton conditions. Irradiation of monosaccharides 
induced the formation of formate and malondialdehyde as
by products, whereas HA predominantly showed cleavage 
of the glycosidic linkages leading to depolymerization. 
Exposure of bovine nasal cartilage to Fenton conditions 
generated increased concentrations of N-acetyl groups and 
formate, indicating depolymerization and degradation 
respectively. No attack on articular collagen was observed. 
Other preliminary studies suggested a close correlation 
between myeloperoxidase activity in RA patients (see 
below) and the content of NMR-detectablc degradation 
products (e.g., N-acetyl groups and acetate). These data 
help support the predominant role of hypochlorous acid 
(HOC1) in HA degradation as HOC1 induces a breakdown 
of glycosidic linkages leading to an increase in the appear- 
ance of N-acetyl groups in NMR spectra. Additionally, 
Schiller et al. [40,41] proposed that HOC1 also reacts with 
N-acetyl groups of monomeric and polymeric arbohydrates 
to give acetate as a final product via a transient, chlorinated 
product. These observations, in combination with the afore- 
mentioned studies, led to their conclusion that HOC1 
serves as the reactive species in vivo. 
The end groups of degraded HA offer additional clues as to 
the mechanism of depolymerization. Uchiyama et al. [42] 
subjected HA to Fenton conditions and further digested 
the resultant fragments with chondroitinase AC-II, which 
yielded the smallest oligosaccharides bearing modified ter- 
minal groups in addition to the disaccharide formed from 
the internal sequences of the fragments. HPLC isolation 
and NMR structure elucidation of the terminal units on 
each fragment indicated the presence of three different end 
groups for both the reducing and nonreducing termini 
(Table 1). These results also indicate that the polymer is 
randomly attacked during degradation, supporting the 
earlier work of Hawkins and Davies [39]. 
The xanthine/xanthine oxidase system (HX/XO) also has 
the potential to cause HA depolymerization. Found pri- 
marily in the liver, xanthine oxidase reacts with xanthine 
to create uric acid and in the process forms oxygen- 
derived free radicals (ODFRs), such as hydrogen peroxide 
and the superoxide radical, that can degrade HA 
(Figure 7). Viscosity measurements performed by Kvam et 
al. [36] indicated that HA depolymerizes rapidly in the 
presence of xanthine and xanthine oxidase, with increased 
rates of depolymerization bserved after the addition of 
iron (III), suggesting Fenton conditions. This study also 
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investigated the effect of ODFRs on chondrocytes, 
finding that ODFRs not only disrupt the glycolytic 
pathway, but also degrade the cellular membrane, leading 
to cartilage damage. 
Polymorphonuclear leucocytes (PMNs), phagocytic ells 
that participate in the immune response, represent another 
class of potential radical-generating a ents. Their respira- 
tory burst releases myeloperoxidase, which works in con- 
junction with hydrogen peroxide and a halide as an 
antimicrobial system within the body. This system in turn 
generates hydrogen peroxide and HOCI (Figure 8). Lind- 
vail and Rydell [43] were able to produce hydroxyl radical 
in the presence of high concentrations of hydrogen perox- 
ide and sodium chloride in a test myeloperoxidase system. 
Varying the concentrations of hydrogen peroxide and 
sodium chloride and alternately eliminating each compo- 
nent from the system indicated that, although sodium chlo- 
ride enhanced egradation to some extent, the system did 
not require hydrogen peroxide for the production of radicals 
and degradation of HA. In addition, potassium iodide and 
potassium bromide, as well as desferrioxamine and manni- 
tol, a radical scavenger, inhibited the degradation process, 
indicating the presence of iron and the involvement of 
Fenton conditions. The observation that chloride ions 
enhanced HA degradation indicated HOC1 participation, 
but they concluded (on the basis of radical stability) that 
hydroxyl radicals probably serves as the destructive agent. 
These results illustrate a need for further studies on the 
effect of HOC1 on HA depolymerization. 
Stimulated neutrophils and myeloperoxidase generate 
HOC1 through the reaction of hydrogen peroxide with 
chloride ions. The accumulation of neutrophils and the 
high concentration of myeloperoxidase in arthritic synovial 
fluid would indicate that HOCI plays a definite role in HA 
degradation in vivo. Viscometry and HPLC experiments 
have shown that HOCI degrades HA [44,45], whereas a 
study of the effect of HOC1 on HA and pig articular carti- 
lage shows that NaOCI attacks the N-acetyl groups of HA 
which degrade to acetate, causing depolymerization 
[46,47]. Researchers observed no breakdown of the sugar 
rings to produce formate and little effect on collagen. 
In their recent report, Hawkins and Davies [48] studied 
the effect of HOCI on HA using electron paramagnetic 
resonance (EPR) and UV spectroscopy, and showed that 
HOC1 initially reacts with the N-acetyl groups of HA. 
Although they did not observe radical trapping upon 
exposure of glucose, galactose and glucuronic acid to 
HOC1, N-acetyl glucosamine showed attack at the 
N-acetyl methyl and cleavage at C(2). ESR data sug- 
gested that attack occurs exclusively at the N-acetyl glu- 
cosamine residues and that initial radical formation occurs 
on the N-acetyl group, which rearranges to yield a carbon- 
centered radical that achieves polymer fragmentation. 
A comparative study of the possible radical-generating 
systems involved in HA degradation would serve to elu- 
cidate the reactive species in vivo. Saari et al. [49] used 
HPLC to monitor the effect of xanthine and xanthine 
oxidase (HX/XO), hydrogen peroxide and HOC1 on syn- 
ovial fluid HA and human umbilical cord HA in vitro. In 
synovial fluid, HX/XO and hydrogen peroxide caused 
depolymerization a d HOCI did not; the HX/XO system 
caused a dramatically greater degree of depolymerization 
than that found in arthritic synovial fluid, however, indi- 
cating that HX/XO is not an important contributor to HA 
depolymerization. In contrast, all of the agents caused 
depolymerization f purified umbilical cord HA, leading 
the authors to conclude that HOC1 performs a scaveng- 
ing action on synovial fluid HA by consuming hydrogen 
peroxide, which forms hydroxyl radical in the presence 
of iron (II). 
NO has recently emerged as a possible factor in cartilage 
damage and arthritis [50]. NO is a key signaling molecule 
in vivo, produced by endothelial cells, macrophages, neu- 
trophils, hepatocytes, chondrocytes, synoviocytes and 
certain classes of neurons. Independent studies have 
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shown increased concentrations of nitrate and nitrite - -  the 
decomposition products of NO - -  in arthritic synovial 
fluid, implicating NO involvement in the development of
arthritis [51,52]. The synovial capillaries, infiltrating leuco- 
cytes and mesenchymal cells all serve as potential sources 
of NO in the joint. Because of the short half-life of NO and 
the amounts of NO produced by endothelial cells, the 
most likely sources are the neutrophils, lymphocytes, mast 
cells and macrophages in inflamed joints, in addition to the 
articular chondrocytes and synovial fibroblasts capable of 
NO synthesis [53,54]. NO gas reduces the viscosity of HA 
solutions under aerobic but not anaerobic onditions, sug- 
gesting the potential involvement of Fenton chemistry 
[50]. Further studies suggest that superoxide interacts with 
NO to form a potent oxidizing agent, and that the presence 
of iron will either enhance or inhibit this reaction depend- 
ing on the relative concentration of each species (Figure 9)
[55]. Connor et al. [56] have shown that the inhibition of 
NO synthase (NOS) will suppress the development of 
arthritis in animal models. Examination of cartilage and 
synovial biopsy samples from osteoarthritic patients 
showed increased expression of inducible NOS (iNOS) in 
chondrocytes, indicating NO participation [57]; the role 
and mechanism of action of NO in arthritis are still largely 
unknown, however. 
Degenerat ion  of  other  matr ix components  
Cartilaginous proteins also serve as targets for degradation 
in arthritis. Heterogeneity and differences in molecular 
Figure 9 
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The interaction ofNO with superoxide produces OH radical, a ROS. 
weight help to characterize the noncollagcnous proteins 
extracted from normal and osteoarthritic cartilage [58]. 
Matrix metalloproteinases (MMPs) are a family of zinc- 
dependent endopeptidases required for cellular migration, 
tissue remodeling and turnover [59]. Tissue inhibitors of 
matrix proteases (TIMPs) regulate the action of MMPs; 
the dysfunction of this regulation can result in a variety of 
disorders including cancer, autoimmune disease and arthri- 
tis. MMPs in cartilage serve to balance out the synthesis of 
new cartilage in matrix turnover; sometimes a disruption in 
this balance of cartilage synthesis and degradation ccurs, 
and degradation exceeds the rate of matrix formation. This 
catalyzes the breakdown of articular cartilage leading to 
arthritis. MMPs in the extracellular matrix include collage- 
nases and gelatinases, which cleave collagen, collagen frag- 
ments and proteoglycans uch as aggrecan. In both 
osteoarthritis and rhernatoid rthritis, these enzymes exist 
at elevated levels, implicating their participation i disease 
[13,60,61]. Two preferred sites for MMP attack exist close 
to the HA-binding site in proteolysis of both aggrecan core 
protein and link protein [62-64]; attack at either of these 
sites disrupts HA binding and causes the loss of proteogly- 
cans from the matrix. Researchers are currently investigat- 
ing the potential of MMP inhibitors for the treatment and 
prevention of arthritic disease. 
Free radical generating systems caninduce damage in col- 
lagen as well [65-70]. Collagen in arthritic artilage xhibits 
increased cross-linking and decreased sensitivity to degra- 
dation by chemical agents. In vitro, collagen exposed to 
Fenton conditions at high iron concentrations exhibited 
signs of degradation, whereas at lower iron concentrations, 
the collagen proved more susceptible to proteolysis, pre- 
sumably due to the destabilization ofthe triple helix [71]. 
Conc lus ions  
Viscometric, spectroscopic, chromatographic and enzymatic 
investigations strongly suggest hat free radicals, NO and 
MMPs participate in the processes of cartilage degenera- 
tion. Myeloperoxidase, xanthine/xanthine oxidase and iron 
(II) systems produce r active oxygen species (hydrogen 
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peroxide, hypochlorous acid, singlet oxygen, superoxide 
radical and hydroxyl radical) capable of degrading HA. 
Analysis of depolymerization products suggests random 
radical attack upon the HA backbone, with little indication 
as to the conditions required for the initial production of 
radical species. The presence of NO by-products in 
arthritic synovial fluid implicates its participation in carti- 
lage degradation as well. Inhibition of NO synthase in 
animal models suppresses the development of arthritis, 
whereas NO gas has been shown to decrease the viscosity 
of HA solutions. Imbalances in MMP activation effects the 
degradation of aggrecan and collagen, depriving cartilage of 
its gel-like character and protective properties. 
Many questions remain as to the molecular events leading 
to synovial inflammation and cartilage degeneration. The 
crucial role of HA degradation i the onset of osteoarthritic 
disorders has spurred the development of a series of high- 
molecular weight HA formulae (e.g. ARTZ ®, Hyalart ®, 
Hyalgan ®, Opelead ® and Synvisc ®) for use in viscosupple- 
mentation therapy [8]. Although these therapies appear to 
reduce pain and augment joint lubrication, these agents 
remain susceptible to the radical-initiated epolymeriza- 
tion processes that plague naturally occurring HA. 
Although effective in the short term, their long-term effec- 
tiveness has yet to be established. 
Despite the lack of a complete, molecular-level picture of 
cartilage degeneration processes, sufficient data exists to 
help guide further development of novel therapeutic 
agents and synthetic matrix replacements for use in the 
treatment of arthritic disorders. For example, Tanaka et al. 
[6] report that activation of protein kinase C, a signaling 
protein found in chondrocytes, prevents stress induced 
osteoarthritic changes in cartilage. Furthermore, they show 
that increased mechanical stress on a system decreases pro- 
teoglycan synthesis and PKC activity. Examination of this 
correlation may lead to a model for the development of 
therapies capable of activating proteoglycan synthesis in 
vivo. A more molecular-level approach might involve the 
inhibition of MMPs, as the ability to regulate cartilage 
turnover would serve to maintain proteoglycan concentra- 
tion within the matrix. 
From a chemist's perspective, the future challenges associ- 
ated with the treatment of osteoarthritic disorders are 
twofold: the continual refinement of the pathways resulting 
in matrix degeneration, and the design and construction of 
new, biocompatible materials for use in replacement thera- 
pies. Biomaterials uch as artificially engineered, highly 
branched forms of HA may be capable of augmenting the 
lubricative properties of the natural matrix without suc- 
cumbing to the oxidative stress responsible for natural HA 
degradation. Future efforts in chemistry will undoubtedly 
continue to address these issues until new, clinically effec- 
tive long-term therapies are generally available. 
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